adult solid tumor
Showing 26 - 50 of >10,000
Solid Tumor, Adult Trial in Xi'an (Bio-008)
Recruiting
- Solid Tumor, Adult
- Bio-008
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of the Chinese People's Liberation
Aug 30, 2023
Circulating Tumor Cells in Solid Tumors
Completed
- Solid Tumor, Adult
- Observational
-
Chapel Hill, North CarolinaRadiation Oncology Clinic - UNC Cancer Hospital
Sep 27, 2022
Solid Tumor Trial in United States (therapeutic nutritional supplementation, white wine, questionnaire administration)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- therapeutic nutritional supplementation
- +2 more
-
Scottsdale, Arizona
- +3 more
Jan 31, 2023
Solid Tumor, Adult Trial in Shanghai (Tislelizumab, Lenvatinib, Cryoablation)
Recruiting
- Solid Tumor, Adult
- Tislelizumab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 13, 2023
Solid Tumor, Adult Trial in Beijing (TY-2699a)
Not yet recruiting
- Solid Tumor, Adult
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
May 18, 2023
Solid Tumor Trial in United States (TR1801-ADC)
Active, not recruiting
- Unspecified Adult Solid Tumor, Protocol Specific
- TR1801-ADC
-
Los Angeles, California
- +4 more
Oct 30, 2022
Advanced Solid Tumors Trial in Switzerland, United States (Debio 0123)
Recruiting
- Advanced Solid Tumors
- Debio 0123
-
Grand Rapids, Michigan
- +3 more
Jan 27, 2023
Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
- Patritumab deruxtecan
- (no location specified)
May 9, 2023
Human Leukocyte Antigen Typing and Tumor Antigen Expression
Recruiting
- Refractory Cancer
- +3 more
-
Chicago, Illinois
- +3 more
Feb 14, 2022
Solid Tumor, Adult Trial in Beijing (HS248 pieces)
Recruiting
- Solid Tumor, Adult
- HS248 pieces
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Mar 6, 2023
Fluoride-labeled Boronophenylalanine PET Imaging in Patients
Not yet recruiting
- Solid Tumor, Adult
- BPA-PET imaging
- (no location specified)
Sep 12, 2022
Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)
Recruiting
- Breast Cancer
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Mar 13, 2023
Solid Tumor, Solid Tumor, Adult Trial (Sargramostim, Ipilimumab-containing therapy)
Suspended
- Solid Tumor
- Solid Tumor, Adult
- Sargramostim
- Ipilimumab-containing therapy
-
Lexington, MassachusettsPartner Therapeutics - No Currently Active Sites
Nov 30, 2022
Advanced Solid Tumor, Metastatic Colorectal Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Irvine, Chicago, Boston
Not yet recruiting
- Advanced Solid Tumor
- +4 more
- FPI-2053
- +2 more
-
Irvine, California
- +2 more
Nov 27, 2023
Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,
Completed
- Adenocarcinoma of the Pancreas
- +3 more
- dovitinib lactate
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Solid Tumor, Adult Trial in Beijing (CD70-targeting CAR-T cells)
Recruiting
- Solid Tumor, Adult
- CD70-targeting CAR-T cells
-
Beijing, Iotherapeutic Department Of Chinsese PLA Gereral Hospital, ChinaChina
Jul 8, 2023
Solid Tumor, Adult Trial in Geneva, Zürich (MVX-ONCO-2)
Withdrawn
- Solid Tumor, Adult
- MVX-ONCO-2
-
Geneva, Switzerland
- +1 more
Jan 27, 2023
Adult Solid Tumor Trial in Canada, United States (RP-6306 (oral PKMYT1 inhibitor))
Recruiting
- Adult Solid Tumor
- RP-6306 (oral PKMYT1 inhibitor)
-
Grand Rapids, Michigan
- +4 more
May 17, 2022